HemoScreen Receives IVDR Certification

PixCell Medical is proud to announce that its groundbreaking HemoScreen CBC analyzer has achieved certification under the new In Vitro Diagnostic Medical Devices Regulation (IVDR) (EU) 2017/746. As the only FDA-cleared, 5-part differential hematology analyzer for point-of-care use, HemoScreen’s IVDR certification represents a significant milestone in advancing hematology diagnostics. It demonstrates PixCell Medical’s commitment to the highest standards of quality and patient safety.

Exhibitor Data Sheet